<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00197678</url>
  </required_header>
  <id_info>
    <org_study_id>HD32257-2</org_study_id>
    <nct_id>NCT00197678</nct_id>
  </id_info>
  <brief_title>Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women</brief_title>
  <official_title>Comparison of Two Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women From Tanzania</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harvard School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Muhimbili University of Health and Allied Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Harvard School of Public Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine effects of daily administration of multivitamin
      supplements at doses resembling the Recommended Dietary Allowance (RDA) during pregnancy to
      HIV positive women decreases the risks of low birth weight (&lt;2500 g), and pre-term birth (&lt;
      37 weeks gestation), compared to multivitamin supplements at doses above the RDA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized clinical trial conducted to examine effects of daily administration of
      multivitamin supplements at doses resembling the Recommended Dietary Allowance (RDA) during
      pregnancy to HIV positive women decreases the risks of low birth weight (&lt;2500 g), and
      pre-term birth (&lt; 37 weeks gestation), compared to multivitamin supplements at doses above
      the RDA. All women receive standard prenatal care, including nevirapine for the prevention of
      mother-to-child transmission of HIV.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2002</start_date>
  <completion_date type="Actual">July 2005</completion_date>
  <primary_completion_date type="Actual">July 2005</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Low birthweight (&lt; 2500 g)</measure>
    <time_frame>Delivery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pre-term birth (&lt; 36 weeks gestation)</measure>
    <time_frame>Monthly until the 32nd week of pregnancy, once every 2 weeks from 32nd to 36th week</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1141</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>Multivitamins-Single RDA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multivitamins at doses resembling a single daily Recommended Dietary Allowance (RDA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multivitamins-Multiples of RDA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Multivitamin supplements at multiples of the Recommended Dietary Allowance (RDA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multivitamins-Multiples of RDA</intervention_name>
    <description>20 mg B1, 20 mg B2, 25 mg B6, 50 mcg B12, 100 mg niacin, 500 mg C, 30 mg E, 0.8 mg folic acid taken orally once per day until 6 weeks after delivery</description>
    <arm_group_label>Multivitamins-Multiples of RDA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multivitamins-Single RDA</intervention_name>
    <description>1.4 mg B1, 1.4 mg B2, 1.9 mg B6, 50 mcg B12, 100 mg niacin, 70 mg C, 10 mg E, and 0.4 mg folic acid taken orally once per day until 6 weeks after delivery</description>
    <arm_group_label>Multivitamins-Single RDA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - HIV-positive pregnant women who are between 12 and 27 weeks gestation who intend to stay
        in Dar es Salaam until delivery.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wafaie W. Fawzi, MD,DrPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard School of Public Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harvard School of Public Health</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Kawai K, Kupka R, Mugusi F, Aboud S, Okuma J, Villamor E, Spiegelman D, Fawzi WW. A randomized trial to determine the optimal dosage of multivitamin supplements to reduce adverse pregnancy outcomes among HIV-infected women in Tanzania. Am J Clin Nutr. 2010 Feb;91(2):391-7. doi: 10.3945/ajcn.2009.28483. Epub 2009 Nov 25.</citation>
    <PMID>19939985</PMID>
  </results_reference>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>November 9, 2010</last_update_submitted>
  <last_update_submitted_qc>November 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Wafaie Fawzi MD, DrPH</name_title>
    <organization>Harvard School of Public health</organization>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>AIDS</keyword>
  <keyword>Multivitamins</keyword>
  <keyword>Pregnancy Outcomes</keyword>
  <keyword>Women</keyword>
  <keyword>Tanzania</keyword>
  <keyword>Africa</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

